Chronic Myeloid Leukemia: Update 2014.

2014-08-28

Guest Editors: Michele Baccarani and Fabrizio Pane

 

A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA Michele Baccarani, Fabrizio Pane | DOI: 10.4084/mjhid.2014.010

e2014010

CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY Lodovico Balducci | DOI: 10.4084/mjhid.2014.037

e2014037

 
  Review Articles

 

Imatinib in Chronic Myeloid Leukemia: an Overview Tomasz Sacha | DOI: 10.4084/mjhid.2014.007

e2014007

MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML) Ibrahim C. Haznedaroglu | DOI: 10.4084/mjhid.2014.009

e2014009

TYROSINE KINASE INHIBITORS AND INTERFERON Maria Dimou, Panagiotis Panagiotidis | DOI: 10.4084/mjhid.2014.006

e2014006

SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs Massimo Breccia, Giuliana Alimena | DOI: 10.4084/mjhid.2014.003

e2014003

TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA Michele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, Francesca Palandri, Gianantonio Rosti | DOI: 10.4084/mjhid.2014.005

e2014005

TYROSINE KINASE INHIBITORS AND PREGNANCY Elisabetta Abruzzese, Malgorzata Monika 
Trawinska, Paolo De Fabritiis, Alessio Pio Perrotti | DOI: 10.4084/mjhid.2014.028

e2014028

DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE   Ibrahim C. Haznedaroglu | DOI: 10.4084/mjhid.2015.014